<!DOCTYPE html>
<!-- Generated by Aspose.Words for .NET 22.7.0 --><html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>fedlex-data-admin-ch-eli-oc-2022-446-it-docx</title>
</head>
<body><div id="lawcontent">
<div id="preface">
<h1 class="erlasstitel botschafttitel ">Ordinanza <br>concernente i certificati attestanti l’avvenuta vaccinazione anti-COVID-19, la guarigione dalla COVID-19 o il risultato di un test COVID-19</h1>
<h2 class="erlasskurztitel ">(Ordinanza sui certificati COVID-19)</h2>
<p>Modifica del 12 agosto 2022</p>
</div>
<div id="preamble">
<p>Il Dipartimento federale dell’interno,</p>
<p>visti gli articoli 23 capoverso 2 e 33 dell’ordinanza del 4 giugno 2021<sup><a href="#fn-d6e21" id="fnbck-d6e21">1</a></sup> sui certificati COVID-19, </p>
<p>ordina:</p>
<div class="footnotes"><p id="fn-d6e21"><sup><a href="#fnbck-d6e21">1</a></sup>  <a href="https://fedlex.data.admin.ch/eli/cc/2021/325" target="_blank">RS <b>818.102.2</b></a></p></div>
</div>
<main id="maintext"><section id="lvl_I"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_I">I </a>
</h1>
<div class="collapseable"><p>Gli allegati 2 e 5 dell’ordinanza del 4 giugno 2021 sui certificati COVID-19 sono modificati secondo la versione qui annessa.</p></div></section><section id="lvl_I_I"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#lvl_I_I">II </a>
</h1>
<div class="collapseable">
<p>La presente ordinanza entra in vigore il 22 agosto 2022.</p>
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				<td>
					
					<p>12 agosto 2022</p>
				</td>
				<td>
					
					<p>Dipartimento federale dell’interno:</p>
					<p>Alain Berset</p>
				</td>
			</tr>
		</table></div>
</div></section></main><div id="annex">
<section id="annex_2"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_2">Allegato 2 </a>
</h1>
<div class="collapseable">
<p class=" man-text-align-left "> (art. 13 cpv. 3, 14, 15 e 33)</p>
<section id="annex_2/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_2/lvl_u1">Disposizioni particolari sui certificati di vaccinazione COVID-19 </a>
</h2>
<div class="collapseable">
<p class=" man-font-style-italic ">N. 3.2, rubrica (concerne solo i testi tedesco e francese) e 3.2.1</p>
<dl>
<dt>3.2.1 </dt>
<dd>Il numero 3.2 si applica ai seguenti vaccini:</dd>
</dl>
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p>Nome(i) del prodotto </p>
				</th>
				<th class=" man-text-align-left ">
					
					<p>Fabbricante</p>
				</th>
			</tr>
			<tr>
				
				<td>
					
					<p>COVID-19 Vaccine Janssen </p>
				</td>
				<td>
					
					<p>Johnson&amp;Johnson</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p>Convidecia (Ad5.CoV2‑S) </p>
				</td>
				<td>
					
					<p>CanSino</p>
				</td>
			</tr>
			
		</table></div>
<p class=" man-font-style-italic ">N. 3.3.1</p>
<dl>
<dt>3.3.1  </dt>
<dd>Il numero 3.3 si applica ai seguenti vaccini:</dd>
</dl>
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p>Nome(i) del prodotto </p>
				</th>
				<th class=" man-text-align-left ">
					
					<p>Fabbricante</p>
				</th>
			</tr>
			<tr>
				
				<td>
					
					<p>Comirnaty <br>(BNT162b2)</p>
				</td>
				<td>
					
					<p>Pfizer/BioNTech</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p>Spikevax <br>(mRNA-1273)</p>
				</td>
				<td>
					
					<p>Moderna</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p>Vaxzevria <br>(ChAdOx1 nCoV-19)</p>
				</td>
				<td>
					
					<p>AstraZeneca</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p>Nuvaxovid <br>(NVX-CoV2373)</p>
				</td>
				<td>
					
					<p>Novavax</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p>BIBP P-CoV</p>
				</td>
				<td>
					
					<p>Sinopharm Wuhan/Sinopharm <br>Beijing</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p>CoronaVac</p>
				</td>
				<td>
					
					<p>Sinovac</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p>Bharat Biotech <br>Covaxin</p>
				</td>
				<td>
					
					<p>Indian Council for Medical <br>Research</p>
				</td>
			</tr>
			<tr>
				
				<td>
					
					<p>Valneva (VLA 2001)</p>
				</td>
				<td>
					
					<p>Valneva</p>
				</td>
			</tr>
			
		</table></div>
</div></section>
</div></section><section id="annex_5"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_5">Allegato 5 </a>
</h1>
<div class="collapseable">
<p class=" man-text-align-left "> (art. 22 e 23 cpv. 1 e 2)</p>
<section id="annex_5/lvl_u1"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_5/lvl_u1">Elenco dei certificati esteri riconosciuti </a>
</h2>
<div class="collapseable">
<p class=" man-font-style-italic ">N. 2.1 e 2.3</p>
<dl>
<dt>2.1 </dt>
<dd>Sono riconosciuti i certificati di vaccinazione, di guarigione e di test che sono interoperabili conformemente al regolamento (UE) 2021/953 e che sono stati emessi dagli Stati e dalle regioni seguenti:<dl>
<dt>– </dt>
<dd>Albania</dd>
<dt>– </dt>
<dd>Andorra</dd>
<dt>– </dt>
<dd>Armenia</dd>
<dt>– </dt>
<dd>Bahrein</dd>
<dt>– </dt>
<dd>Benin</dd>
<dt>– </dt>
<dd>Capo Verde</dd>
<dt>– </dt>
<dd>El Salvador</dd>
<dt>– </dt>
<dd>Georgia</dd>
<dt>– </dt>
<dd>Isole Färöer</dd>
<dt>– </dt>
<dd>Israele</dd>
<dt>– </dt>
<dd>Kosovo</dd>
<dt>– </dt>
<dd>Macedonia del Nord</dd>
<dt>– </dt>
<dd>Marocco</dd>
<dt>– </dt>
<dd>Moldova</dd>
<dt>– </dt>
<dd>Monaco</dd>
<dt>– </dt>
<dd>Montenegro</dd>
<dt>– </dt>
<dd>Panama</dd>
<dt>– </dt>
<dd>Regno Unito</dd>
<dt>– </dt>
<dd>San Marino</dd>
<dt>– </dt>
<dd>Santa Sede (Città del Vaticano)</dd>
<dt>– </dt>
<dd>Serbia</dd>
<dt>– </dt>
<dd>Seychelles</dd>
<dt>– </dt>
<dd>Thailandia</dd>
<dt>– </dt>
<dd>Turchia</dd>
<dt>– </dt>
<dd>Ucraina</dd>
<dt>– </dt>
<dd>Uruguay</dd>
<dt>– </dt>
<dd>Vietnam</dd>
</dl>
</dd>
<dt>2.3 </dt>
<dd>Sono riconosciuti i certificati di vaccinazione che sono interoperabili conformemente al regolamento (UE) 2021/953 e che sono stati emessi dagli Stati e dalle regioni seguenti:<dl>
<dt>– </dt>
<dd>Colombia</dd>
<dt>– </dt>
<dd>Ecuador</dd>
<dt>– </dt>
<dd>Filippine</dd>
<dt>– </dt>
<dd>Giordania</dd>
<dt>– </dt>
<dd>Indonesia</dd>
<dt>– </dt>
<dd>Libano</dd>
<dt>– </dt>
<dd>Madagascar</dd>
<dt>– </dt>
<dd>Oman</dd>
<dt>– </dt>
<dd>Perù</dd>
<dt>– </dt>
<dd>Repubblica di Corea</dd>
<dt>– </dt>
<dd>Tunisia</dd>
</dl>
</dd>
</dl>
</div></section>
</div></section>
</div>
</div></body>
</html>
